Long-term Outcome Recruiting Phase 4 Trials for Ropivacaine (DB00296)

Back to Long-term Outcome
IndicationStatusPhase
DBCOND0081476 (Long-term Outcome)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03629483Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve BlockPrevention